WHO ICTRP trial

The effect of total intravenous anesthesia with remimazolam versus sevoflurane…

ChiCTR2500095670 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500095670
Public title The effect of total intravenous anesthesia with remimazolam versus sevoflurane inhalation anesthesia on postoperative agitation in patients undergoing laparoscopic gastric and colorectal cancer surgery
Scientific title The effect of total intravenous anesthesia with remimazolam versus sevoflurane inhalation anesthesia on postoperative agitation in patients undergoing laparoscopic gastric and colorectal cancer surgery: a clinical randomized controlled study
Primary sponsor People's Hospital of Jianyang City
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Emergence Agitation , EA
Interventions Remimazolam group:Intravenous infusion of remimazolam during surgery;Sevoflurane group:Inhalation of sevoflurane during surgery
Registration date Jan 10, 2025
Target size Remimazolam group:54;Sevoflurane group:54
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations